Medplus Health Services Share Price Target 2027: 17.9% Upside to Rs 715, Bull Rs 857
- November 11, 2026
- Posted by: Chaitanya Auti
- Category: Market
Medplus Health Services share price Rs 606.60 (11 November 2026). Base target Rs 715, bull Rs 857, downside risk Rs 477. PE 33.95. 52W range Rs 565.60 to Rs 1,022.20.
Quick Answer
The Medplus Health Services share price target for 2027 is Rs 715, about 17.9% above the current price of Rs 606.60. The bull case is Rs 857, and the downside risk level, which is not a target, is Rs 477. The base case assumes earnings per share grow 20.0% a year, a cap applied because the FY24 to FY26 pace was 83.2%, with the stock holding its PE of 33.95. These are model-based estimates built from reported financials, not guaranteed outcomes.
Investors weighing a Medplus Health Services target price for 2027 should start with where the stock sits today. At Rs 606.60 on 11 November 2026, it is 40.7% below its 52-week high of Rs 1,022.20 and 7.2% above its 52-week low of Rs 565.60. That range spans 81% from low to high, so the entry point matters as much as the Medplus Health Services price forecast itself.
This article builds the Medplus Health Services share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario states its assumptions, so you can trace how the base case, the bull case and the downside risk level were reached and test them against your own view.
Click Here – Get Free Investment Predictions
Medplus Health Services Stock Analysis: Company Overview and Key Stats
Medplus Health Services (NSE: MEDPLUS) has a market capitalisation of Rs 7,164 crore. In FY26 it reported revenue of Rs 6,964 crore and net profit of Rs 219.61 crore. The table collects the figures the Medplus Health Services share price target is built on.
| Metric | Value |
|---|---|
| Company | Medplus Health Services |
| NSE Ticker | MEDPLUS |
| CMP (11 November 2026) | Rs 606.60 |
| 52-Week High | Rs 1,022.20 |
| 52-Week Low | Rs 565.60 |
| Market Cap | Rs 7,164 crore |
| PE Ratio (TTM) | 33.95 |
| Industry PE | 64.69 |
| Price to Book | 3.46 |
| Return on Equity | 10.20% |
| Debt to Equity | 0.75 |
| EPS (TTM) | Rs 17.56 |
| Dividend Yield | 0.00% |
| 12-Month Base Target | Rs 715 |
| Bull Case | Rs 857 |
| Downside Risk Level (not a target) | Rs 477 |
Why Is Medplus Health Services Share Price Target Set at Rs 715 for 2027?
The arithmetic is short. Trailing EPS of Rs 17.56 grown for one year gives a forward EPS estimate of Rs 21.07, and multiplying it by the unchanged PE of 33.95 gives the Rs 715 base-case Medplus Health Services stock target. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.
Earnings Growth Behind the Medplus Health Services Target Price: Five Years of Results
Medplus Health Services grew revenue from Rs 3,811 crore in FY22 to Rs 6,964 crore in FY26, a compound annual growth rate of 16.3%. Net profit grew faster, from Rs 94.72 crore to Rs 219.61 crore (23.4% a year), which shows margin gains did part of the work and not just higher sales.
| Financial Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Dividend per Share (Rs) |
|---|---|---|---|---|
| FY22 | 3,810.64 | 94.72 | 8.52 | 0.00 |
| FY23 | 4,603.65 | 50.10 | 4.17 | 0.00 |
| FY24 | 5,664.86 | 65.58 | 5.45 | 0.00 |
| FY25 | 6,184.67 | 150.23 | 12.52 | 0.00 |
| FY26 | 6,963.79 | 219.61 | 18.29 | 0.00 |
FY26 revenue growth was 12.6%, slower than the four-year average of 16.3%, and net profit moved up 46.2%. EPS rose from Rs 5.45 in FY24 to Rs 18.29 in FY26. The FY27 outlook for the Medplus Health Services price target depends on whether that EPS estimate keeps compounding.
Margins and the Latest Quarter
Medplus Health Services converted 3.2% of FY26 revenue into net profit, against 2.4% in FY25, within a five-year range of 1.1% to 3.2%. EBITDA margin was 9.7% in FY26 versus 8.7% in FY25.
In the September 2026 quarter, revenue was Rs 2,058 crore, up 21.3% from the same quarter a year earlier, while net profit of Rs 56.07 crore was up 1.0%. EBITDA came in at Rs 190.60 crore, up 14.6% year on year. The next quarterly result is the first test of whether the earnings assumption behind the Medplus Health Services stock target holds.
Balance Sheet and Cash Flow
Debt to equity stands at 0.75, and shareholders’ equity grew from Rs 1,417 crore in FY22 to Rs 1,975 crore in FY26. Operating cash flow in FY26 was Rs 495.58 crore against capital expenditure of Rs 123.03 crore, leaving free cash flow of Rs 372.55 crore, or 5.2% of the current market capitalisation. In FY25 free cash flow was Rs 480.98 crore.
Valuation Check for the Medplus Health Services Stock Target: PE, Price to Book and ROE
At a PE of 33.95 against an industry PE of 64.69, Medplus Health Services trades at a discount to its industry. Price to book is 3.46 on a book value of Rs 172.13 per share, and return on equity is 10.20%. A PE of 33.95 equals an earnings yield of 2.9%, and the FY26 dividend of Rs 0.00 per share gives a yield of 0.00%.
Shareholding Pattern and Institutional Holding
Promoters held 40.19% of Medplus Health Services in September 2026, and promoter holding has stayed near 40.19% since September 2025. Foreign institutional investors (FII) held 12.58% and domestic institutions (DII) held 31.89%, which puts total institutional holding at 44.47%. FII holding fell from 16.54% in September 2025 to 12.58% in September 2026. Public shareholders own the remaining 15.34%. A meaningful institutional holding adds a layer of research coverage and trading depth.
Medplus Health Services Share Price Targets for the Short Term and 12 Months
Short Term Medplus Health Services Stock Target Levels: Technical Setup
At Rs 606.60 on 11 November 2026, Medplus Health Services trades below its 50-day simple moving average of Rs 633.66 and below its 200-day exponential moving average of Rs 733.60. The 14-day RSI reads 54.4, which is neutral territory, and the MACD line sits above its signal line. The nearest resistance level is Rs 633.66 (50-day simple moving average) and the nearest support is Rs 565.60 (52-week low). A sustained move above Rs 633.66 would improve the short-term setup, while a close below Rs 565.60 would shift attention to the next support.
12 Month Medplus Health Services Target Price for 2027
The 12-month target of Rs 715 means a move of 17.9% up from Rs 606.60 over the next 12 months. It would still leave the stock 30.1% below its 52-week high of Rs 1,022.20. Anyone checking the Medplus Health Services share price target against their own view should focus on two inputs: the EPS estimate and the PE multiple.
How EPS Growth and PE Multiple Change the Medplus Health Services Target Price
| EPS Growth | PE 27.16 | PE 33.95 | PE 39.04 |
|---|---|---|---|
| 0.0% (EPS Rs 17.56) | Rs 477 | Rs 596 | Rs 686 |
| 20.0% (EPS Rs 21.07) | Rs 572 | Rs 715 | Rs 823 |
| 25.0% (EPS Rs 21.95) | Rs 596 | Rs 745 | Rs 857 |
Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Medplus Health Services price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.
Bull Case and Downside Risk for Medplus Health Services Stock Target in 2027
Bull Case Rs 857
The bull case Medplus Health Services price target needs EPS growth of 25.0%, which lifts forward EPS to Rs 21.95, and a PE multiple that rises 15% to 39.04. That gives Rs 857, 41.3% above the current price and below the 52-week high of Rs 1,022.20.
Downside Risk Level Rs 477
The downside risk level is not a target. It assumes EPS stays flat at Rs 17.56 and the PE falls 20% to 27.16. That gives Rs 477, 21.4% below the current price and below the 52-week low of Rs 565.60.
| Scenario | EPS Growth | PE Multiple | Price (Rs) | Change vs CMP |
|---|---|---|---|---|
| Bull Case | 25.0% | 39.04 | Rs 857 | +41.3% |
| Base Case | 20.0% | 33.95 | Rs 715 | +17.9% |
| Downside Risk | 0.0% | 27.16 | Rs 477 | -21.4% |
Key Risks to the Medplus Health Services Target Price for 2027
Growth Slowdown Risk for the Medplus Health Services Price Target
Revenue in the September 2026 quarter was up 21.3% year on year, and FY26 revenue growth was 12.6%. If growth slows from here, the EPS estimate behind the Medplus Health Services stock target will need revising.
Liquidity and Size Risk
Medplus Health Services has a market capitalisation of Rs 7,164 crore. Institutional holding is 44.47%, and promoters hold 40.19%. Stocks of this size are usually liquid, though exits can take longer than entries when the market is falling.
Valuation and Margin Risk
Net margin was 3.2% in FY26, so a small slip in costs moves profit noticeably. At a PE of 33.95 versus an industry PE of 64.69, a de-rating toward the downside-risk PE of 27.16 would cut the price even if earnings hold.
Market and Technical Risk
Technical indicators add short-term risk: the 14-day RSI is 54.4 and the MACD sits above its signal line. A broad fall in the Nifty 50 or the Sensex can override company fundamentals for weeks at a time.
How to Invest in Medplus Health Services
Start with the live price and volume. Any Medplus Health Services share price target is only as current as the data behind it, and the data here is as of 11 November 2026, so refresh the Rs 606.60 price before acting on any level.
Next, review the fundamentals yourself. The Univest Screener lets you check Medplus Health Services’ PE, ROE, debt and shareholding in one place.
Check Medplus Health Services fundamentals on the Univest Screener
Then compare the three Medplus Health Services target price scenarios with your own view. If you expect EPS growth below 20.0%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.
Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.
Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.
Download the Univest iOS App or Univest Android App to track Medplus Health Services live price and get daily stock recommendations.
Conclusion
The Medplus Health Services share price target for 2027 is Rs 715 in the base case, with Rs 857 as the bull case. The support for that view is arithmetic you can check: EPS grew 83.2% a year over FY24 to FY26, and the stock trades at a PE of 33.95. The risks are equally concrete, including a net margin of just 3.2% that leaves profit sensitive to costs and a downside scenario that cuts the price 21% if earnings stall. Use these numbers as a framework for judging the Medplus Health Services price target, check them against the latest filings, and size any position to your own risk appetite.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Medplus Health Services Share Price Target 2027
What is the Medplus Health Services share price target for 2027?
Ans. The base-case Medplus Health Services share price target for 2027 is Rs 715, which is 17.9% above the price of Rs 606.60 on 11 November 2026. The bull case is Rs 857 and the downside risk level, which is not a target, is Rs 477. All three come from one method: forward EPS multiplied by a PE multiple, using only reported results. They are model estimates and not guaranteed outcomes, and the next quarterly result is the first check on the EPS assumption.
What is the Medplus Health Services share price today?
Ans. As of 11 November 2026, 9:53 AM IST, Medplus Health Services (NSE: MEDPLUS) trades at Rs 606.60, up 1.78% on the day. That is 40.7% below the 52-week high of Rs 1,022.20 and 7.2% above the 52-week low of Rs 565.60. The market capitalisation of Rs 7,164 crore places it among mid-cap stocks. Prices change through the trading session, so check the live quote before acting on any level in this article.
Is Medplus Health Services a buy or sell at the current price?
Ans. The data points both ways. On the positive side, EPS has grown 83.2% a year over FY24 to FY26 and the base case implies 17.9% upside; on the cautious side, the net margin is a thin 3.2%, and the downside risk level of Rs 477 is 21% below the current price. Whether Medplus Health Services fits your portfolio depends on your time horizon, position size and risk appetite. Consult a SEBI-registered advisor before investing, as this article is not investment advice.
What are the bull case target and downside risk level for Medplus Health Services shares?
Ans. The bull case in the Medplus Health Services share price target for 2027 is Rs 857, which assumes 25.0% EPS growth and a PE of 39.04, a 15% re-rating from today’s multiple. That is 41.3% above the current price and below the 52-week high of Rs 1,022.20. The downside risk level is Rs 477, which assumes flat EPS and a PE of 27.16, 20% lower than today. It sits 21.4% below the current price and below the 52-week low of Rs 565.60, and it marks a risk to watch, not a target.
What are the main risks to the Medplus Health Services price target?
Ans. Four risks matter most for the Medplus Health Services share price target: slower revenue or profit growth, a PE de-rating, thin liquidity or size risk, and weakness in the broader market. With a market capitalisation of Rs 7,164 crore, the stock is usually liquid, though exits can take longer than entries in a falling market. A fall to the downside-risk PE of 27.16 would cut the price even if earnings hold.
What is the PE ratio of Medplus Health Services and how does it compare with the industry?
Ans. The PE ratio of Medplus Health Services is 33.95, against an industry PE of 64.69, which is a discount to the industry. Price to book is 3.46 and return on equity is 10.20%, and the PE equals an earnings yield of 2.9%. The base case holds the PE unchanged, so the Medplus Health Services share price target moves only with earnings, while the bull and downside scenarios change the multiple by +15% and -20%.
Who owns Medplus Health Services, and what is the promoter holding?
Ans. Promoters held 40.19% of Medplus Health Services in September 2026. FII held 12.58%, DII held 31.89% and the public held 15.34%. Together the two institutional groups hold 44.47%. Shareholding is filed every quarter, so it is worth rechecking after each result.
What were Medplus Health Services’ latest quarterly results?
Ans. In the September 2026 quarter, Medplus Health Services reported revenue of Rs 2,058 crore (up 21.3% year on year) and net profit of Rs 56.07 crore (up 1.0%). For comparison, FY26 full-year revenue growth was 12.6% and net profit moved up 46.2%. Each new quarter either supports or weakens the EPS growth of 20.0% assumed in the base case.